Andrew Hill

44.0k citations
480 papers · 18.1k · 7 hit papers · h-index 61

Impact in

  • Oncology top 0.2%
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies
    • Colorectal Cancer Surgical Treatments
  • Surgery top 0.1%
    • Enhanced Recovery After Surgery
    • Anesthesia and Pain Management

Papers in

    • Enhanced Recovery After Surgery 51
    • Anesthesia and Pain Management 30
    • Anorectal Disease Treatments and Outcomes 25
    • Cancer Immunotherapy and Biomarkers 35
    • Colorectal Cancer Surgical Treatments 24
    • CAR-T cell therapy research 22

Andrew Hill

451 papers receiving 17.5k citations

Andrew Hill's Hit Papers

Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142 2022 · 167 citations
1670+9+19Years since publication50010001.5k2.0k

Peers

Andrew Hill
Comparison fields: 5 of 205
  • Oncology 5.6k
  • Surgery 6.6k
  • Pathology and Forensic Medicine 1.5k
  • Cardiology and Cardiovascular Medicine 1.8k
  • Pulmonary and Respiratory Medicine 2.4k
Replace Daniel H. Solomon with:
Daniel H. Solomon United States
María E. Suarez‐Almazor United States
Timothy M. Pawlik United States
Julie Ann Sosa United States
Karen M. Kuntz United States
Chul Ahn United States
Anders Ekbom Sweden
Sherine E. Gabriel United States
Maarten Boers Netherlands
Kenneth G. Saag United States
Andrew Hill relative to Daniel H. Solomon United States Daniel H. Solomon's profile →
Citations per field
00.5×1.5×2.4×
Daniel H. Solomon · 1×
Citations per year

Countries citing papers authored by Andrew Hill

Since Specialization
Citations

This map shows the geographic impact of Andrew Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Hill more than expected).

Fields of papers citing papers by Andrew Hill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Hill. The network helps show where Andrew Hill may publish in the future.

Co-authors

The 25 scholars most cited alongside Andrew Hill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew Hill Line = papers co-authored together Andrew Hill links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 480 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
Hit paper breakdown →
20172047
2
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
Hit paper breakdown →
20181478
3
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
Hit paper breakdown →
20181049
4
Guidelines for Perioperative Care in Elective Colonic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
Hit paper breakdown →
2012840
5
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.
Hit paper breakdown →
1997709
6
Guidelines for perioperative care in elective colonic surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations
Hit paper breakdown →
2012632
7 2011319
8 2013280
9 2016266
10 2007219
11
Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142
Hit paper breakdown →
2022167
12 2009165
13 2013165
14 2008149
15 2008137
16 2008135
17 2012134
18 2018127
19
Investigação por questionário
2012124
20
Tools for Demographic Estimation
2013124

About Andrew Hill

Andrew Hill is a scholar working on Surgery, Oncology, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health, having authored 480 papers that have together received 18.1k indexed citations. Recurring topics across this work include Enhanced Recovery After Surgery (51 papers), Cardiac, Anesthesia and Surgical Outcomes (45 papers), Cancer Immunotherapy and Biomarkers (35 papers), Anesthesia and Pain Management (30 papers), Anorectal Disease Treatments and Outcomes (25 papers), Colorectal Cancer Surgical Treatments (24 papers), CAR-T cell therapy research (22 papers) and Aortic aneurysm repair treatments (17 papers). The work is most often cited by research in Oncology (5.6k citations), Surgery (6.6k citations), Pathology and Forensic Medicine (1.5k citations), Cardiology and Cardiovascular Medicine (1.8k citations) and Pulmonary and Respiratory Medicine (2.4k citations). Andrew Hill has collaborated with scholars based in New Zealand, United States and Australia. Frequent co-authors include Tarik Sammour, Arman Kahokehr, Andrew D. MacCormick, Sanket Srinivasa, Daniel P. Lemanu, Michael J. Overman, Sara Lonardi, Thierry André, Scott Kopetz and Kamran Zargar‐Shoshtari. Their work appears in journals such as ANZ Journal of Surgery, Journal of Clinical Oncology, Journal of Surgical Research, World Journal of Surgery and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact